SENS

[BACK TO ARTICLES]

2020-08-26 05:11:00 PM

Iress
AIP: ADCOCK INGRAM HOLDINGS LIMITED - Appointment of a Non-Executive Director
AIP: ADCOCK INGRAM HOLDINGS LIMITED - Appointment of a Non-Executive Director
Appointment of a Non-Executive Director
Adcock Ingram Holdings Limited
(Incorporated in the Republic of South Africa)
Registration number 2007/016236/06
Share code: AIP
ISIN: ZAE000123436
("Adcock Ingram" or "the Company")
Appointment of a Non-Executive Director
In accordance with paragraph 3.59 of the Listings Requirements of the JSE Limited, shareholders are
advised of the appointment of Prof Michael "Mike" Sathekge as a Non-Executive Director of the Company
and Risk & Sustainability Committee, with effect from 25 August 2020.
Chairman, Mr Lindsay Ralphs commented: "I wish to express my sincere appreciation to Prof Sathekge for
agreeing to join our Board. Notwithstanding the uncertainty brought by Covid-19, Prof Sathekge joins the Board at a
very exciting time. I have no doubt that the Company will benefit from his insight and considerable experience. I look
forward to his contribution to the future success of the Company."
Abridged curriculum vitae
Prof Michael Sathekge is a Professor and Head of Department of Nuclear Medicine at the University of
Pretoria and Steve Biko Academic Hospital. He is one of the Editors in Chief of the Seminars of Nuclear
Medicine Journal, an Editor for the Image of the Month for European Journal of Nuclear Medicine and
Molecular Imaging, and an associate Editor of The World Journal of Nuclear Medicine. Prof Sathekge is
also a Chairman and Director of Nuclear Medicine Research Infrastructure.
He is President-Elect of the World Association of Radiopharmaceuticals and Molecular Therapy. His past
experience includes being a former Chairman of the Medical Research Council Board. Prof Sathekge is a
former President of the Colleges of Medicine of South Africa, former President of International Society of
Radiolabeled Blood Elements, and former Chairman of Technical & Investment Committee: Board of
Nuclear Technology Products.
The Board wishes Prof Sathekge well in his new role.
Midrand
26 August 2020
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 26-08-2020 05:11:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
   Source: JSE News Service (SENS)
[BACK TO ARTICLES]